npj Journals

A new #AI tool developed by Northwestern scientists, called iSeg, may improve accuracy and consistency in #cancer care, per @Nature_NPJ Precision Oncology. news.feinberg.northwestern.edu/2025/07/01/ai-…

🚀 #ADCs targeting immune-checkpoints? Check out our latest review in @Nature_NPJ Precision Oncology! Promising early trials & the future of #ImmunoOncology 📖 Read here: nature.com/articles/s4169… @MOcchipintiMD @AriMarinel @GLoRussoMD_PhD

Nice writeup on our recent paper @Nature_NPJ PO, thanks to @tonyvanwitsen. Using AI, we found biological differences in endometrial tumors that help explain why Black women face 80% higher mortality. ⚠️ “One-size-fits-all” AI models fail Black women. news.emory.edu/stories/2025/0…

We’ve extended our submission deadline for the @Nature_NPJ Precision Oncology special issue to Oct 14, 2025. Feel free to message me directly. We’ve gotten some great submissions so far and would love to get more! nature.com/collections/bb…

1/ Happy to share our latest piece in @Nature_NPJ precision oncology: "Plasma epigenomic profiling reveals treatment-emergent squamous transformation in prostate cancer". Work co-led with @KarlSemaan with great mentorship from @Jberchuck @SylvanBacaLab #MattFreedman @DrChoueiri…

A project initiated by the @SU2C Breast Cancer Dream Team was published in @Nature_NPJ Precision Oncology utilizing cohort-level and individual networks to predict best response in patients with metastatic triple negative breast cancer nature.com/articles/s4169…

Excited to share our paper on AI-based prediction of disease progression in squamous skin cancers in @Nature_NPJ! Great collaboration w Juan Pisula & @bozeklab using federated learning & explainable AI for high accuracy while preserving patient privacy: nature.com/articles/s4169…

🤔How can we ⬆️ access to innovation for ALL 🌎🌍🌏patients with #breastcancer @BIGxResearch 📝 @Nature_NPJ Free access link 👉rdcu.be/ev9HQ Successes of the past ✅ Pitfalls of the present ✅ Solutions for the future eg @Path4Young✅ 🙏to co-✍️& funders 💶

📢 New open-access article in npj Breast Cancer, co-authored by BIG’s leadership, explores the challenges of academic clinical trials and how to ensure their future impact. 📄 Read more: nature.com/articles/s4152… #BIGAgainstBreastCancer #breastcancer #research @Nature_NPJ

🚨 Excited to share our manuscript in @Nature_NPJ highlighting the expanding role of liquid biopsy to detect clinically actionable non-genomic mechanisms of therapeutic resistance. Led by @KarlSemaan @RashadNawfal with collaborators @SylvanBacaLab @DrChoueiri #MattFreedman.

New study from @AlumkalJoshi lab identifies a cellular signature that explains why about one-third of prostate cancers respond especially poorly to treatment. Read the paper in @Nature_NPJ Precision Oncology: nature.com/articles/s4169… Read our summary: michmed.org/gVrAB

Excited to share this molecular case report in @Nature_NPJ led by @KarlSemaan and @RashadNawfal. I expect to see more of this rare resistance mechanism with advances in AR-targeting therapy. Great colab with @Jberchuck, @DrChoueiri, and #MattFreedman. nature.com/articles/s4169…

🚨 Check out our molecular case report, just in @Nature_NPJ, on plasma epigenomic profiling to detect squamous transformation in prostate cancer. Work possible thanks to outstanding mentors @jberchuck @SylvanBacaLab @DrChoueiri #MattFreedman Tweetorial by ⭐️ @RashadNawfal and…

We need nutritional screening in every cancer patient, even normal weight, through body composition & at molecular level. Patients' stratification can help us assess nutritional/metabolic risks of inflammatory implications in cancer #lipidomic @Nature_NPJ nature.com/articles/s4152…

Dr. Frederick Wilson + colleagues have identified RASGRF1/2 fusions across a variety of tumor types, gaining insight on incidence, structural diversity, + tissue distribution of this distinct fusion class. 🔗 nature.com/articles/s4169… @Nature_NPJ @SmilowCancer @TempusAI

#NewResearch in @Nature_NPJ precision oncology: “Tissue-based genomic profiling of 300,000 tumors highlights the detection of variants with low allele fraction.” Explore the publication here: spkl.io/6015ABS9H

🚨 Just out in @Nature_NPJ Precision Oncology! 📊 Using #AI & multi-omics, we uncover distinct immune architectures & prognostic features in African-American vs European-American women with #EndometrialCancer. 🔗 Read more: tinyurl.com/yc2pdyp4 #AI #Pathomics #HealthEquity

🚀 Excited to share our new review in @Nature_NPJ Precision Oncology: “Mucin-1: A Promising Pan-Cancer Therapeutic Target” nature.com/articles/s4169… We discuss: ✅ How aberrant MUC1 expression and glycosylation drive oncogenesis in solid and hematologic cancers ✅ The pipeline of…

Our new paper is out @Nature_NPJ Precision Oncology! rdcu.be/eujnK With @JustinWattsMD and colleagues @SylvesterCancer we report on the first patient functionally cured by single-agent IDH1 inhibition with Olutasidenib @RigelPharma for r/r #AML @NaturePortfolio 🧵

🚨 New paper in @Nature_NPJ Precision Oncology! We show that radiomics + pathomics improves prediction of recurrence in early NSCLC, ICI response in advanced NSCLC, & chemo response in SCLC. 📌 A step forward in #AI precision oncology for lung cancer. 🔗 rdcu.be/eppuU